Exercise program for patients with Hidradenitis Suppurativa
Physical Activity and Hidradenitis Suppurativa: a Novel Controlled Trial Investigating Functional Performance and Activity Limitations and Assessing the Benefits of an Outcome Measures Driven Exercise Program
NA · University of Miami · NCT06015438
This study is testing a new exercise program designed specifically for people with Hidradenitis Suppurativa to see if it can help them be more active and improve their quality of life.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | University of Miami (other) |
| Locations | 1 site (Miami, Florida) |
| Trial ID | NCT06015438 on ClinicalTrials.gov |
What this trial studies
This study aims to identify the barriers to physical activity faced by patients with Hidradenitis Suppurativa (HS) and to develop an exercise program tailored to their needs. The program will utilize evidence-based techniques to encourage participation in physical activity. The outcomes of this exercise program will be evaluated to determine its effectiveness in improving the quality of life for HS patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 80 who have a confirmed diagnosis of moderate-to-severe Hidradenitis Suppurativa.
Not a fit: Patients who are not adults, pregnant women, prisoners, or those unable to comply with study procedures may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could enhance the physical activity levels and overall well-being of patients suffering from Hidradenitis Suppurativa.
How similar studies have performed: While there may be limited studies specifically targeting exercise interventions for HS, similar approaches in other chronic conditions have shown positive outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults 18 years old to 80 years old * Have diagnosis of HS confirmed by a dermatologist * Able to provide informed consent * For the extended portion of the study: Classified as having moderate-to-severe HS as per the IHS-4 criteria Exclusion Criteria: * Individuals who are not yet adults * Women known to be pregnant * Prisoners * Subjects, who in the opinion of the PI, cannot comply with the study procedures
Where this trial is running
Miami, Florida
- University of Miami — Miami, Florida, United States (RECRUITING)
Study contacts
- Principal investigator: Hadar Lev-Tov, MD — University of Miami
- Study coordinator: Hadar V Lev-Tov, MD
- Email: hlevtov@med.miami.edu
- Phone: 3052431953
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hidradenitis Suppurativa